Walleye Capital
BNGO icon

Walleye Capital’s Bionano Genomics BNGO Stock Holding History

Walleye Capital’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$417K Buy
+87
New +$371K 0.19% 145

Other funds holding BNGO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital's BNGO Position: Q3 2018 in Review

Walleye Capital opened a new position in Bionano Genomics (BNGO) in Q3 2018: 87 shares worth $417K. The stake represents 0.19% of the portfolio and ranks #145 among its holdings.

8 funds tracked by Wall St. Rank hold BNGO as of Q3 2018.

  • Walleye Capital held 87 shares of Bionano Genomics worth $417K as of Q3 2018.
  • Bionano Genomics was a new Walleye Capital position in Q3 2018.
  • Bionano Genomics made up 0.19% of Walleye Capital's portfolio in Q3 2018, its #145 holding.
  • 8 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2018.

Based on Walleye Capital's 13F filing for Q3 2018, filed 14 Nov 2018.